New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
about
Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriersA unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from PolandRecurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern PolandClinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review.Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in BRCA1 and BRCA2.Genome-wide association studies and epigenome-wide association studies go together in cancer control.New single nucleotide polymorphisms (SNPs) in homologous recombination repair genes detected by microarray analysis in Polish breast cancer patients.Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway.Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family.IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma.BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer.
P2860
Q31159863-B67C17D4-7877-4977-9535-F3F28F64A0EAQ33823472-8BF8C4C1-46C2-4EFB-B692-CC0AF14185BEQ34521706-3B61F30D-CF3C-4D69-A010-12EA8A60D0AFQ36252996-1846E327-6146-48C8-B561-08EA59B2179BQ36303235-21CE7F81-F8C4-4526-BF8A-8311876D9A49Q36538025-EB49E92F-D1AC-4FB4-B1DC-044C94508A32Q38573701-6E1C1278-DF3E-4C7F-805F-46A184659DD3Q38600659-43E77997-76B2-43EA-AD3A-E171BB3093DAQ38845359-611BF004-B5B9-4197-B284-2CC53F94709EQ38881089-051E3AB1-18C4-4BBD-B9C9-935D20EC9190Q47619082-045A4672-14AE-4CA4-BBE0-A26341FBAA97Q48172763-2CD5B3F7-D506-45DC-8DF7-834B99F8C7F4Q48534893-623696E8-DE8C-4980-B5F6-11D2E92FD514Q49332955-B44FDD82-0E78-4D0C-8A72-11EACDF463FFQ52629240-1BBA2D9F-463C-4ED8-8DD2-F44685534133Q55080436-F571E857-50D6-4963-BC9C-6DB085C9B317
P2860
New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
New recurrent BRCA1/2 mutation ...... by next generation sequencing
@ast
New recurrent BRCA1/2 mutation ...... by next generation sequencing
@en
type
label
New recurrent BRCA1/2 mutation ...... by next generation sequencing
@ast
New recurrent BRCA1/2 mutation ...... by next generation sequencing
@en
prefLabel
New recurrent BRCA1/2 mutation ...... by next generation sequencing
@ast
New recurrent BRCA1/2 mutation ...... by next generation sequencing
@en
P2860
P50
P1433
P1476
New recurrent BRCA1/2 mutation ...... by next generation sequencing
@en
P2093
Dorota Nowakowska
P2860
P2888
P356
10.1186/S12920-015-0092-2
P577
2015-05-07T00:00:00Z
P5875
P6179
1008137335